Community Spotlight: How Chief Advancement Officer Nicole Capossela is Collaborating for a Cure
From her very first day, Nicole Capossela brought an unmistakable sense of purpose, passion, and possibility to the Lupus...
Lupus Therapeutics Partners with AbbVie on Clinical Trial Recruitment Efforts in SLE Through LuCIN Lupus Clinical Trial Network
Lupus Therapeutics Partners with AbbVie on Clinical Trial Recruitment Efforts in SLE Through LuCIN Lupus Clinical Trial Network
The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced a partnership with AbbVie Inc. for the Phase 3 development of upadacitinib (RINVOQ®) as a potential treatment for people living with systemic lupus erythematosus (SLE). Lupus Therapeutics will assist with recruiting participants to join the study, activation of each study site and engaging sites to join the study through the Lupus Clinical Investigators Network (LuCIN) of top academic centers throughout North America.
The full press release is available on the Lupus Therapeutics website.
